PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR's UP!, page-82

  1. 300 Posts.
    lightbulb Created with Sketch. 38
    most big pharma deals are done during the Phase III trials prior to completion of the trial. we don't need a big pharma deal as we have sufficient funds to complete the phase III alone
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.